MSL.CA Profile & Description — Merus Labs International Inc (New)
Merus Labs International is engaged in the acquisition and licensing of branded prescription pharmaceutical products in Canada, U.S. and Europe. Co.'s products include Vancocin®, an antibiotic used to treat a disease resulting from the infection of Clostridium Difficile and Emselex®/Enable®, a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.